Vaginal Slings Market By Type (Conventional Vaginal Slings, Advanced Vaginal Slings), By End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Vaginal Slings Market

Vaginal slings, also known as pubovaginal sling procedure is defined as a type of surgical procedure, which helps control stress urinary incontinence in women. Women suffering from severe urinary incontinence lose bladder control and are hence advised by the doctors to undergo vaginal sling surgeries for the treatment of urinary incontinence

Vaginal sling surgeries have gained traction in recent years, owing to increase in preference for the treatment of urinary incontinence. Women suffering from urinary incontinence experience urine leakage after coughing or sneezing, and severe urinary incontinence affects the patient’s daily life, where vaginal sling procedure becomes essential. Rise in the number of women experiencing urinary incontinence, especially stress urinary incontinence across the globe is set to propel the vaginal slings market growth. In addition, soaring female geriatric population, and increase in need for vaginal sling product, drive the growth of the vaginal slings industry. The increasing geractric female  population  boosts the market growth as geriatric population is prone to urinary incontinence issues. However, lack of awareness among patients regarding vaginal sling procedures hampers the market growth. Nevertheless, the technologically advanced vaginal sling product, and increase in number of vaginal slings industry, offers profitable opportunities for the expansion of the market.

The vaginal slings market share is segmented into type, end user, and region. On the basis of type, the market is segregated into conventional vaginal slings and advanced vaginal slings. The conventional vaginal slings segment dominated the market in 2020, and this trend is expected to continue during the vaginal slings market forecast period, owing to high utilization of biomaterials, autologous cells, and allogenic cells in the development of vaginal slings.

Depending on end user, the vaginal slings market share is bifurcated into hospitals, clinics, and others. The hospitals exhibited the highest growth in 2020, and is expected to lead during the forecast period, owing to the large scale utilization of vaginal slings and increase in preference of the geriatric population for surgical treatment of urinary incontinence in hospitals.

North America garnered a major share of the vaginal slings market analysis in 2020, and is expected to continue to dominate during the forecast period, owing to early adoption of novel vaginal slings along with increasing prevalence of stress urinary incontinence among women in this region. However, Asia-Pacific is expected to register highest CAGR of 12.3% from 2021 to 2030, owing to the high population base, growing disposable incomes, and rise in awareness among patient about advanced urinary incontinence management.

The COVID-19 outbreak is anticipated to have a negative impact on growth of the global vaginal slings market. The COVID-19 pandemic stressed healthcare systems globally. Surgical procedures are profoundly affected by the COVID-19 pandemic. A number of clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Implementation of lockdown, owing to the COVID-19 outbreak resulted in the decline in the number of elective surgeries performed globally.

Key Findings Of The Study

By type, the conventional vaginal slings segment was the highest contributor to the market in 2020.

On the basis of end user, the hospital segment dominated the market in 2020, and is expected to continue this trend during the forecast period.

Region-wise, North America garnered the largest revenue share in 2020. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Overview

The global vaginal slings market was valued at $1,074.8 million in 2020, and is projected to reach $3,302.5 million by 2030, registering a CAGR of 12.4% from 2021 to 2030. In women, stress urinary incontinence is known to be a social disease that can be caused by various contributing factors, such as natural childbirth, obesity, hormonal deficiencies, and changes in collagen fibers. Vaginal slings are incorporated in the surgical procedures used to treat stress urinary incontinence in women, using different types of vaginal slings, such as synthetic slings, natural slings, and single-incision slings. The key factors that drive the market growth include, rise in the incidence of stress urinary incontinence and increase in the female geriatric population. In addition, keen interest of market players in the development of materially advanced vaginal slings and rise in the demand for single-incision vaginal slings supplement the market growth.

The vaginal slings market is segmented on the basis of type, end user, and region. By type, the market is classified into conventional vaginal slings and advanced vaginal slings. On the basis of end user, it is classified into hospitals, clinics, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.  The major companies profiled in this report include A.M.I. GmbH, B. Braun Melsungen AG, Betatech Medical, Boston Scientific Corporation, Coloplast, Cousin Biotech, Caldera Medical Medtronic PLC, Neomedic International, and Promedon Group.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the antibacterial coatings market analysis from 2020 to 2030 to identify the prevailing antibacterial coatings market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the antibacterial coatings market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global antibacterial coatings market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

Promedon Grou

Scope of Vaginal Slings Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Conventional Vaginal Slings

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Advanced Vaginal Slings

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Hospitals

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Clinics

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Others

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key trends and opportunities

6.2.2 North America Market size and forecast, by Type

6.2.3 North America Market size and forecast, by End User

6.2.4 North America Market size and forecast, by country

6.2.4.1 U.S.

6.2.4.1.1 Market size and forecast, by Type

6.2.4.1.2 Market size and forecast, by End User

6.2.4.2 Canada

6.2.4.2.1 Market size and forecast, by Type

6.2.4.2.2 Market size and forecast, by End User

6.2.4.3 Mexico

6.2.4.3.1 Market size and forecast, by Type

6.2.4.3.2 Market size and forecast, by End User

6.3 Europe

6.3.1 Key trends and opportunities

6.3.2 Europe Market size and forecast, by Type

6.3.3 Europe Market size and forecast, by End User

6.3.4 Europe Market size and forecast, by country

6.3.4.1 Germany

6.3.4.1.1 Market size and forecast, by Type

6.3.4.1.2 Market size and forecast, by End User

6.3.4.2 France

6.3.4.2.1 Market size and forecast, by Type

6.3.4.2.2 Market size and forecast, by End User

6.3.4.3 United Kingdom

6.3.4.3.1 Market size and forecast, by Type

6.3.4.3.2 Market size and forecast, by End User

6.3.4.4 Italy

6.3.4.4.1 Market size and forecast, by Type

6.3.4.4.2 Market size and forecast, by End User

6.3.4.5 Spain

6.3.4.5.1 Market size and forecast, by Type

6.3.4.5.2 Market size and forecast, by End User

6.3.4.6 Rest of Europe

6.3.4.6.1 Market size and forecast, by Type

6.3.4.6.2 Market size and forecast, by End User

6.4 Asia-Pacific

6.4.1 Key trends and opportunities

6.4.2 Asia-Pacific Market size and forecast, by Type

6.4.3 Asia-Pacific Market size and forecast, by End User

6.4.4 Asia-Pacific Market size and forecast, by country

6.4.4.1 China

6.4.4.1.1 Market size and forecast, by Type

6.4.4.1.2 Market size and forecast, by End User

6.4.4.2 Japan

6.4.4.2.1 Market size and forecast, by Type

6.4.4.2.2 Market size and forecast, by End User

6.4.4.3 Australia

6.4.4.3.1 Market size and forecast, by Type

6.4.4.3.2 Market size and forecast, by End User

6.4.4.4 India

6.4.4.4.1 Market size and forecast, by Type

6.4.4.4.2 Market size and forecast, by End User

6.4.4.5 Rest of Asia-Pacific

6.4.4.5.1 Market size and forecast, by Type

6.4.4.5.2 Market size and forecast, by End User

6.5 LAMEA

6.5.1 Key trends and opportunities

6.5.2 LAMEA Market size and forecast, by Type

6.5.3 LAMEA Market size and forecast, by End User

6.5.4 LAMEA Market size and forecast, by country

6.5.4.1 Brazil

6.5.4.1.1 Market size and forecast, by Type

6.5.4.1.2 Market size and forecast, by End User

6.5.4.2 Turkey

6.5.4.2.1 Market size and forecast, by Type

6.5.4.2.2 Market size and forecast, by End User

6.5.4.3 Saudi Arabia

6.5.4.3.1 Market size and forecast, by Type

6.5.4.3.2 Market size and forecast, by End User

6.5.4.4 South Africa

6.5.4.4.1 Market size and forecast, by Type

6.5.4.4.2 Market size and forecast, by End User

6.5.4.5 Rest of LAMEA

6.5.4.5.1 Market size and forecast, by Type

6.5.4.5.2 Market size and forecast, by End User

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Key developments

8.1 A.M.I. GmbH

8.1.1 Company overview

8.1.2 Company snapshot

8.1.3 Operating business segments

8.1.4 Product portfolio

8.1.5 Business performance

8.1.6 Key strategic moves and developments

8.2 B. BRAUN MELSUNGEN AG

8.2.1 Company overview

8.2.2 Company snapshot

8.2.3 Operating business segments

8.2.4 Product portfolio

8.2.5 Business performance

8.2.6 Key strategic moves and developments

8.3 Betatech Medical

8.3.1 Company overview

8.3.2 Company snapshot

8.3.3 Operating business segments

8.3.4 Product portfolio

8.3.5 Business performance

8.3.6 Key strategic moves and developments

8.4 Boston Scientific Corporation

8.4.1 Company overview

8.4.2 Company snapshot

8.4.3 Operating business segments

8.4.4 Product portfolio

8.4.5 Business performance

8.4.6 Key strategic moves and developments

8.5 coloplast

8.5.1 Company overview

8.5.2 Company snapshot

8.5.3 Operating business segments

8.5.4 Product portfolio

8.5.5 Business performance

8.5.6 Key strategic moves and developments

8.6 cousin biotech

8.6.1 Company overview

8.6.2 Company snapshot

8.6.3 Operating business segments

8.6.4 Product portfolio

8.6.5 Business performance

8.6.6 Key strategic moves and developments

8.7 Caldera Medical

8.7.1 Company overview

8.7.2 Company snapshot

8.7.3 Operating business segments

8.7.4 Product portfolio

8.7.5 Business performance

8.7.6 Key strategic moves and developments

8.8 Medtronic plc

8.8.1 Company overview

8.8.2 Company snapshot

8.8.3 Operating business segments

8.8.4 Product portfolio

8.8.5 Business performance

8.8.6 Key strategic moves and developments

8.9 neomedic international

8.9.1 Company overview

8.9.2 Company snapshot

8.9.3 Operating business segments

8.9.4 Product portfolio

8.9.5 Business performance

8.9.6 Key strategic moves and developments

8.10 Promedon Group

8.10.1 Company overview

8.10.2 Company snapshot

8.10.3 Operating business segments

8.10.4 Product portfolio

8.10.5 Business performance

8.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL VAGINAL SLINGS MARKET, BY TYPE, 2020-2030,($MILLION)

TABLE 2. VAGINAL SLINGS MARKET REVENUE, FOR CONVENTIONAL VAGINAL SLINGS, BY REGION , 2020-2030,($MILLION)

TABLE 3. VAGINAL SLINGS MARKET CONVENTIONAL VAGINAL SLINGS BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. VAGINAL SLINGS MARKET REVENUE, FOR ADVANCED VAGINAL SLINGS, BY REGION , 2020-2030,($MILLION)

TABLE 5. VAGINAL SLINGS MARKET ADVANCED VAGINAL SLINGS BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. GLOBAL VAGINAL SLINGS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 7. VAGINAL SLINGS MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)

TABLE 8. VAGINAL SLINGS MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)

TABLE 9. VAGINAL SLINGS MARKET REVENUE, FOR CLINICS, BY REGION , 2020-2030,($MILLION)

TABLE 10. VAGINAL SLINGS MARKET CLINICS BY COUNTRY, 2020-2030,($MILLION)

TABLE 11. VAGINAL SLINGS MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)

TABLE 12. VAGINAL SLINGS MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)

TABLE 13. VAGINAL SLINGS MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 14. NORTH AMERICA VAGINAL SLINGS MARKET, BY TYPE, 2020-2030,($MILLION)

TABLE 15. NORTH AMERICA VAGINAL SLINGS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 16. NORTH AMERICA VAGINAL SLINGS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 17. U.S. VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 18. U.S. VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 19. CANADA VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 20. CANADA VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 21. MEXICO VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 22. MEXICO VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 23. EUROPE VAGINAL SLINGS MARKET, BY TYPE, 2020-2030,($MILLION)

TABLE 24. EUROPE VAGINAL SLINGS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 25. EUROPE VAGINAL SLINGS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 26. GERMANY VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 27. GERMANY VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 28. FRANCE VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 29. FRANCE VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 30. UNITED KINGDOM VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 31. UNITED KINGDOM VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 32. ITALY VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 33. ITALY VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 34. SPAIN VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 35. SPAIN VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 36. REST OF EUROPE VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 37. REST OF EUROPE VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 38. ASIA-PACIFIC VAGINAL SLINGS MARKET, BY TYPE, 2020-2030,($MILLION)

TABLE 39. ASIA-PACIFIC VAGINAL SLINGS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 40. ASIA-PACIFIC VAGINAL SLINGS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 41. CHINA VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 42. CHINA VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 43. JAPAN VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 44. JAPAN VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 45. AUSTRALIA VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 46. AUSTRALIA VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 47. INDIA VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 48. INDIA VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 49. REST OF ASIA-PACIFIC VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 50. REST OF ASIA-PACIFIC VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 51. LAMEA VAGINAL SLINGS MARKET, BY TYPE, 2020-2030,($MILLION)

TABLE 52. LAMEA VAGINAL SLINGS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 53. LAMEA VAGINAL SLINGS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 54. BRAZIL VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 55. BRAZIL VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 56. TURKEY VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 57. TURKEY VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 58. SAUDI ARABIA VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 59. SAUDI ARABIA VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 60. SOUTH AFRICA VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 61. SOUTH AFRICA VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 62. REST OF LAMEA VAGINAL SLINGS MARKET BY TYPE 2020-2030,($MILLION)

TABLE 63. REST OF LAMEA VAGINAL SLINGS MARKET BY END USER 2020-2030,($MILLION)

TABLE 64.A.M.I. GMBH: COMPANY SNAPSHOT

TABLE 65.A.M.I. GMBH: OPERATING SEGMENTS

TABLE 66.A.M.I. GMBH: PRODUCT PORTFOLIO

TABLE 67.A.M.I. GMBH: NET SALES,

TABLE 68.A.M.I. GMBH: KEY STRATERGIES

TABLE 69.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

TABLE 70.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS

TABLE 71.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO

TABLE 72.B. BRAUN MELSUNGEN AG: NET SALES,

TABLE 73.B. BRAUN MELSUNGEN AG: KEY STRATERGIES

TABLE 74.BETATECH MEDICAL: COMPANY SNAPSHOT

TABLE 75.BETATECH MEDICAL: OPERATING SEGMENTS

TABLE 76.BETATECH MEDICAL: PRODUCT PORTFOLIO

TABLE 77.BETATECH MEDICAL: NET SALES,

TABLE 78.BETATECH MEDICAL: KEY STRATERGIES

TABLE 79.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 80.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS

TABLE 81.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 82.BOSTON SCIENTIFIC CORPORATION: NET SALES,

TABLE 83.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES

TABLE 84.COLOPLAST: COMPANY SNAPSHOT

TABLE 85.COLOPLAST: OPERATING SEGMENTS

TABLE 86.COLOPLAST: PRODUCT PORTFOLIO

TABLE 87.COLOPLAST: NET SALES,

TABLE 88.COLOPLAST: KEY STRATERGIES

TABLE 89.COUSIN BIOTECH: COMPANY SNAPSHOT

TABLE 90.COUSIN BIOTECH: OPERATING SEGMENTS

TABLE 91.COUSIN BIOTECH: PRODUCT PORTFOLIO

TABLE 92.COUSIN BIOTECH: NET SALES,

TABLE 93.COUSIN BIOTECH: KEY STRATERGIES

TABLE 94.CALDERA MEDICAL: COMPANY SNAPSHOT

TABLE 95.CALDERA MEDICAL: OPERATING SEGMENTS

TABLE 96.CALDERA MEDICAL: PRODUCT PORTFOLIO

TABLE 97.CALDERA MEDICAL: NET SALES,

TABLE 98.CALDERA MEDICAL: KEY STRATERGIES

TABLE 99.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 100.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 101.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 102.MEDTRONIC PLC: NET SALES,

TABLE 103.MEDTRONIC PLC: KEY STRATERGIES

TABLE 104.NEOMEDIC INTERNATIONAL: COMPANY SNAPSHOT

TABLE 105.NEOMEDIC INTERNATIONAL: OPERATING SEGMENTS

TABLE 106.NEOMEDIC INTERNATIONAL: PRODUCT PORTFOLIO

TABLE 107.NEOMEDIC INTERNATIONAL: NET SALES,

TABLE 108.NEOMEDIC INTERNATIONAL: KEY STRATERGIES

TABLE 109.PROMEDON GROUP: COMPANY SNAPSHOT

TABLE 110.PROMEDON GROUP: OPERATING SEGMENTS

TABLE 111.PROMEDON GROUP: PRODUCT PORTFOLIO

TABLE 112.PROMEDON GROUP: NET SALES,

TABLE 113.PROMEDON GROUP: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.VAGINAL SLINGS MARKET SEGMENTATION

FIGURE 2.VAGINAL SLINGS MARKET,2020-2030

FIGURE 3.VAGINAL SLINGS MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.VAGINAL SLINGS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.VAGINAL SLINGS MARKET,BY TYPE,2020(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CONVENTIONAL VAGINAL SLINGS VAGINAL SLINGS MARKET,2020-2030(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ADVANCED VAGINAL SLINGS VAGINAL SLINGS MARKET,2020-2030(%)

FIGURE 15.VAGINAL SLINGS MARKET,BY END USER,2020(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HOSPITALS VAGINAL SLINGS MARKET,2020-2030(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CLINICS VAGINAL SLINGS MARKET,2020-2030(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS VAGINAL SLINGS MARKET,2020-2030(%)

FIGURE 19.VAGINAL SLINGS MARKET BY REGION,2020

FIGURE 20.U.S. VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 21.CANADA VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 22.MEXICO VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 23.GERMANY VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 24.FRANCE VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 25.UNITED KINGDOM VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 26.ITALY VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 27.SPAIN VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 28.REST OF EUROPE VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 29.CHINA VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 30.JAPAN VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 31.AUSTRALIA VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 32.INDIA VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 33.REST OF ASIA-PACIFIC VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 34.BRAZIL VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 35.TURKEY VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 36.SAUDI ARABIA VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 37.SOUTH AFRICA VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 38.REST OF LAMEA VAGINAL SLINGS MARKET,2020-2030($MILLION)

FIGURE 39. TOP WINNING STRATEGIES, BY YEAR

FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 42.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 43.COMPETITIVE DASHBOARD

FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 45.A.M.I. GMBH.: NET SALES ,($MILLION)

FIGURE 46.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)

FIGURE 47.BETATECH MEDICAL.: NET SALES ,($MILLION)

FIGURE 48.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)

FIGURE 49.COLOPLAST.: NET SALES ,($MILLION)

FIGURE 50.COUSIN BIOTECH.: NET SALES ,($MILLION)

FIGURE 51.CALDERA MEDICAL.: NET SALES ,($MILLION)

FIGURE 52.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 53.NEOMEDIC INTERNATIONAL.: NET SALES ,($MILLION)

FIGURE 54.PROMEDON GROUP.: NET SALES ,($MILLION